Biomerica, Henry Schein enter marketing services agreement for inFoods IBS test

Biomerica (BMRA) announced today a marketing services arrangement with Henry Schein (HSIC) to market Biomerica’s inFoods Irritable Bowel Syndrome, IBS, test in the United States, excluding New York State. Henry Schein’s nationwide distribution network will provide marketing support for the inFoods IBS test to primary care and gastroenterology specialty practices. “We are thrilled to partner with Henry Schein to bring inFoods IBS test to more patients and providers across the country,” said Zack Irani, CEO of Biomerica. “Their national reach and proven track record in delivering innovative medical products will help accelerate adoption of our non-drug, personalized solution for IBS management.”